- recruitingPHASE1
Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]GRT6019
This study is looking at how a new drug called GRT6019 is handled by the body in healthy men. Researchers want to understand exactly how much of the drug is absorbed, how it's broken down, and how it leaves the body.
United Kingdom - not yet recruitingPHASE1
A Study in Healthy Male Participants to Compare How CHF10196 Affects How the Body Absorbs and Processes Two Commonly Used Medicines: Dabigatran, a Blood Thinner, and Rosuvastatin, a Medicine Used to Lower Cholesterol
This study looks at how a new medicine, CHF10196, might affect two common drugs: dabigatran (a blood thinner) and rosuvastatin (for cholesterol). We need healthy men to help us understand these interactions, making sure future medicines are safe when taken together.
United Kingdom